Optimization of α-Fluoro, β-Heteroaryl Acrylamide Warheads for KRAS G12C Active-State Inhibition
- 2 March 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 69 (5) , 5935-5943
Abstract
We provide herein a detailed investigation of the warhead reactivity and pharmaceutical properties of a novel α-fluoro, β-heteroaryl acrylamide class of covalent warhead in the context of KRASG12C active-state inhibition. Unlike traditional unsubstituted acrylamide warheads, which undergo conjugate addition with cysteine at the β-position, these acrylamides react at the α-position in a vinylogous nucleophilic aromatic substitution (SNAr) transformation. Systematic examination of pyridine warhead substitutions and bioisosteric replacements elucidated a dependence of these warheads' reactivity on heterocycle basicity in addition to electrophilicity. In vitro characterization revealed the effects of heterocycle identity on cellular potency, free fraction, permeability, and efflux ratio. These lessons informed in vivo studies, culminating in the discovery of a lead molecule that showed low clearance across species and robust efficacy in a mouse xenograft model.Keywords
This publication has 36 references indexed in Scilit:
- Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRASG12C InhibitorJournal of Medicinal Chemistry, 2022
- Discovery of AZD4625, a Covalent Allosteric Inhibitor of the Mutant GTPase KRASG12CJournal of Medicinal Chemistry, 2022
- The advantages of describing covalent inhibitor in vitro potencies by IC50 at a fixed time point. IC50 determination of covalent inhibitors provides meaningful data to medicinal chemistry for SAR optimizationBioorganic & Medicinal Chemistry, 2021
- Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer TherapeuticsJournal of Medicinal Chemistry, 2020
- KRAS: From undruggable to a druggable Cancer TargetCancer Treatment Reviews, 2020
- Synthesis of α‐Fluorinated Acrylates by a Palladium‐Catalyzed Decarboxylative Olefination ReactionEuropean Journal of Organic Chemistry, 2018
- Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapiesDrug Discovery Today, 2015
- Oxazoles2008
- The Reactivity of 2‐Fluoro‐ and 2‐Chloropyridines toward Sodium Ethoxide: Factors Governing the Rates of Nucleophilic (Het)Aromatic SubstitutionsHelvetica Chimica Acta, 2005
- Quaternization of Heteroaromatic Compounds: Quantitative Aspects1978